METHIMAZOLE RESISTANCE IN GRAVES' DISEASE
Keywords:
Graves' Disease, methimazole, methimazole resistanceAbstract
CASE
In this case series, we present 4 Filipino patients with Graves' disease who range in age from 22 to 51, 3 of whom were female. At first, beta-blockers and methimazole (MMI) were used for treatment. However, even at the highest doses of MMI, hyperthyroidism was not controlled during serial thyroid function monitoring. These patients were deemed to have methimazole resistance. Treatment was shifted to high-dose propylthiouracil (PTU), to which they became responsive, at least initially. After becoming euthyroid or nearly euthyroid, they underwent radioactive iodine ablation (RAIA). Post-ablation, thyrotoxicosis was controlled, and they were maintained on levothyroxine supplementation thereafter. These cases highlight an important yet uncommon clinical entity of methimazole-resistant Graves' disease. The success of the regimen, shifting MMI to PTU, followed by RAIA once euthyroid, offers clinicians a guide to managing these not-so-common cases.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Krizia Marie Lim, Magnolia Sibulo, Oliver Allan Dampil
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
